Keras (2015)
Additional Assessments That Can Help DEXA scans are often combined with other tests to provide a full picture of your metabolic health
Summary: Yes, Wegovy (semaglutide 2.4 mg) can cause headaches as a common adverse effect, typically emerging during initial treatment weeks and dose escalation
others need extended time at lower doses before advancing

Some had been accused of taking the easy way out. I think that there is kind of a stigma that its a cop-out, one participant said, that youre just taking the easy way out rather than doing it with diet and exercise like you should. Reflecting on the findings, de Vere Hunt shares, I expected perceived stigma to be present for people taking GLP-1 RA medications, but I was surprised by how strongly it still emerged in interviews. A particularly important finding, she added, was that many participants felt society viewed GLP-1 use differently depending on the reason: diabetes treatment was seen as legitimate, while obesity treatment was often framed as cheating. Biologically this doesnt make much sense, de Vere Hunt said, as obesity is also a chronic disease involving dysregulated hormonal and metabolic pathways with serious long-term health implications. Yet eligibility criteria, she said, can reinforce the misconception that people do not need medical support to treat obesity alone